EyePoint Pharmaceuticals, Inc. — Director's Dealing 2018

Aug 3, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: EyePoint Pharmaceuticals, Inc. (EYPT)
CIK: 0001314102
Period of Report: 2018-08-01

Reporting Person: Price David (Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-08-01	Employee Stock Option (right to buy)	$2.22	A	385000	Acquired	2028-08-01	Common Stock (385000)	Direct

Footnotes

F1: The option to purchase will vest and become exercisable in three equal annual installments beginning August 1, 2019.